Loading clinical trials...
Loading clinical trials...
Umbilical Cord Blood Therapy for Cerebral Palsy: a Randomized,Double-blind, Placebo-controlled Trial
This randomized controlled study aims to evaluate the efficacy of umbilical cord blood therapy for children with cerebral palsy.
Cerebral palsy is a disorder of movement and posture resulted from a non-progressive lesion or injury of the immature brain. It is a leading cause of childhood onset disability. Many experimental animal studies have revealed that umbilical cord blood is useful to repair neurological injury in brain. On the basis of many experimental studies, umbilical cord blood is suggested as a potential therapy for cerebral palsy.
Age
0 - 20 years
Sex
ALL
Healthy Volunteers
No
CHA Bundang Medical Center, CHA University
Seongnam-si, Gyeonggi-do, South Korea
Start Date
February 1, 2012
Primary Completion Date
July 1, 2012
Completion Date
July 1, 2012
Last Updated
July 18, 2012
37
ACTUAL participants
Umbilical Cord Blood Infusion
BIOLOGICAL
Placebo Umbilical Cord Blood
OTHER
Active Rehabilitation
OTHER
Lead Sponsor
MinYoung Kim, M.D.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07168577